Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other 23Gastrointestinal 23Breast 9Lymphoid 7Other hematologic neoplasm 6Genitourinary 5Gynecologic 4Head & Neck 3Endocrine 3Classical hematology 3Thoracic 2Dermatologic 2Plasma cell 1Other solid neoplasm 1Myeloid 1

Conditions

Lung Neoplasms 3642Carcinoma, Non-Small-Cell Lung 3583Small Cell Lung Carcinoma 576Breast Neoplasms 419Neoplasms 299Adenocarcinoma of Lung 248Colorectal Neoplasms 222Melanoma 201Mesothelioma, Malignant 183Pancreatic Neoplasms 179Prostatic Neoplasms 178Brain Neoplasms 178Head and Neck Neoplasms 172Neoplasm Metastasis 167Ovarian Neoplasms 153Esophageal Neoplasms 152Mesothelioma 145Colonic Neoplasms 140Stomach Neoplasms 139NSCLC 115Pleural Effusion, Malignant 114Carcinoma, Renal Cell 109Urinary Bladder Neoplasms 105Disease 96Sarcoma 85Uterine Cervical Neoplasms 82Thymoma 79Liver Neoplasms 77Motor Activity 75Squamous Cell Carcinoma of Head and Neck 72

Interventions

Sulfonylurea Compounds 1Sodium-Glucose Transporter 2 Inhibitors 1Dipeptidyl-Peptidase IV Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus, Type 2 × Thoracic × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT00782366 2011-04-27

PGT

Mayo Clinic

Completed
26 enrolled
BreastGastrointestinalGenitourinaryOtherThoracic

Atrial Fibrillation, Breast Neoplasms, Celiac Disease, Colonic Neoplasms, Diabetes Mellitus, Type 2, Graves Disease, Lung Neoplasms, Myocardial Infarction, Obesity, Osteoarthritis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡